For many cancer patients, time is the most precious resource. Yet the journey from discovering a promising drug compound to delivering it to patients can take 10–15 years and cost an average of $2.6 billion per drug (Tufts Centre for the Study of Drug Development, 2016). During that time, millions
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```